Falcon's Beyond Global, Inc Class A Common Stock (FBYD) had the lowest return between October 1, 2023 and October 15, 2023 by a small-cap US stock or small-cap US stock, returning -99.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Falcon's Beyond Global, Inc Class A Common Stock (FBYD) | 10/1/2023 - 10/15/2023 | -99.72% |
Ventyx Biosciences (VTYX) | 10/1/2023 - 10/15/2023 | -46.32% |
Penguin Solutions (PENG) | 10/1/2023 - 10/15/2023 | -46.09% |
Standard Biotools (LAB) | 10/1/2023 - 10/15/2023 | -45.73% |
ProKidney (PROK) | 10/1/2023 - 10/15/2023 | -39.39% |
Hyliion (HYLN) | 10/1/2023 - 10/15/2023 | -38.05% |
Babcock & Wilcox Enterprises (BW) | 10/1/2023 - 10/15/2023 | -34.38% |
Neuropace (NPCE) | 10/1/2023 - 10/15/2023 | -32.32% |
InMode (INMD) | 10/1/2023 - 10/15/2023 | -32.15% |
Applied Opt (AAOI) | 10/1/2023 - 10/15/2023 | -31.36% |
Tango Therapeutics (TNGX) | 10/1/2023 - 10/15/2023 | -31.34% |
Neumora Therapeutics (NMRA) | 10/1/2023 - 10/15/2023 | -31.18% |
ATRenew Inc DRC (RERE) | 10/1/2023 - 10/15/2023 | -31.03% |
Gyre Therapeutics (GYRE) | 10/1/2023 - 10/15/2023 | -30.61% |
Enhabit (EHAB) | 10/1/2023 - 10/15/2023 | -30.54% |
Annexon (ANNX) | 10/1/2023 - 10/15/2023 | -30.04% |
Taysha Gene Therapies (TSHA) | 10/1/2023 - 10/15/2023 | -28.93% |
Clear Channel Outdoor (CCO) | 10/1/2023 - 10/15/2023 | -28.85% |
Oatly Group AB ADR (OTLY) | 10/1/2023 - 10/15/2023 | -28.44% |
A10 Network (ATEN) | 10/1/2023 - 10/15/2023 | -27.32% |
Nanobiotix (NBTX) | 10/1/2023 - 10/15/2023 | -27.25% |
RAPT Therapeutics (RAPT) | 10/1/2023 - 10/15/2023 | -26.62% |
Castle Biosciences (CSTL) | 10/1/2023 - 10/15/2023 | -26.48% |
Bally's (BALY) | 10/1/2023 - 10/15/2023 | -26.23% |
Quanterix (QTRX) | 10/1/2023 - 10/15/2023 | -25.97% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
